Details of the Drug | DrugMAP

General Information of Drug (ID: DM17N47)

Drug Name

CJC-1134-PC

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C26H47N7O9S
Canonical SMILES: C1C(C(=O)N(C1=O)CCC(=O)NCCOCCOCC(=O)NCCCCNCCCCC(C(=O)N)N)SCC(C(=O)O)N
InChI: 1S/C26H47N7O9S/c27-18(24(29)37)5-1-2-7-30-8-3-4-9-31-22(35)16-42-14-13-41-12-10-32-21(34)6-11-33-23(36)15-20(25(33)38)43-17-19(28)26(39)40/h18-20,30H,1-17,27-28H2,(H2,29,37)(H,31,35)(H,32,34)(H,39,40)/t18-,19-,20?/m0/s1
InChIKey: MSFZPBXAGPYVFD-NFBCFJMWSA-N

Cross-matching ID

PubChem CID: 86278325
CAS Number: 1031700-39-6
TTD ID: D09MHC

References

1	2005 approvals: Safety first. Nature Reviews Drug Discovery 5, 92-93 (February 2006).